Mebeverine

DRUG4 trials

Sponsors

Hazel Everitt, Abbott, Tanta University

Conditions

Functional Bowel DisorderIBS - Irritable Bowel SyndromeIrritable Bowel SyndromePost-cholecystectomy Gastrointestinal Spasms

Phase 3

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

RecruitingNCT04217733

Tanta UniversityIBS - Irritable Bowel Syndrome

Start: 2019-11-01End: 2030-12-30Target: 60Updated: 2020-01-03

Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bowel Disorders

CompletedNCT05175131

AbbottFunctional Bowel Disorder

Start: 2020-11-27End: 2021-05-18Updated: 2025-09-16

Phase 4

Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)

CompletedNCT00934973

Hazel EverittIrritable Bowel Syndrome

Start: 2010-04-30End: 2011-10-31Updated: 2021-04-30

Unknown Phase

Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointestinal Spasm

CompletedNCT02260154

AbbottPost-cholecystectomy Gastrointestinal Spasms

Start: 2015-07-31End: 2016-10-31Updated: 2019-06-06

Related Papers

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of Inflammation Research2022-02-012 citations

Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome

Journal of Clinical Pharmacy and Therapeutics2021-11-0212 citations

Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.

2013-04-2152 citations